# Marie-Claire Daveu

> Marie-Claire Daveu is a Series A investor at Kering backing Biotechnology and Fashion. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Kering](https://shizune.co/investors/profile/kering)
- Total investments: 2
- Last investment: Jan 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/marie-claire-daveu-2a9235a7/

Marie-Claire Daveu is a Series A investor at Kering focused on Biotechnology and Fashion. Marie-Claire Daveu is the Chief Sustainability Officer and Head of international institutional affairs at Kering. Following a career as a senior civil servant in France, Marie-Claire joined the private sector to encourage the adoption of sustainability in business. During her tenure at Kering, she has been responsible for the overarchingsustainability strategy of the Group and has guided the pioneering leadership in sustainability that Kering is recognized for in the fashion industry.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Fashion | 1 | 50% |
| 3D Printing | 1 | 50% |
| Health Care | 1 | 50% |
| 3D Technology | 1 | 50% |

6 industries tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Italy | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SQIM | SQIM is a biotechnological based agency. | $12.1M | Series A | Jan 11, 2024 |  |
| VitroLabs | VitroLabs is a startup working on the cutting edge of 3D tissue engineering using stem cell-based technologies. The company develops a fully scalable tissue engineering platform combining the latest breakthroughs in stem cell research and biomaterials. It manufactures real leather without the need to raise and slaughter animals using breakthroughsin stem cell research and tissue engineering.VitroLabs was founded on 2016 and is based in San Jose, California. | $47.4M | Series A | May 04, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [European Circular Bioeconomy Fund](https://shizune.co/investors/profile/european-circular-bioeconomy-fund) — VC Fund, 2 deals together
- [Agronomics](https://shizune.co/investors/profile/agronomics-d560) — VC Fund, 1 deal together
- [Bestseller’s Invest Fwd](https://shizune.co/investors/profile/bestseller-s-invest-fwd) — VC Fund, 1 deal together
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund, 1 deal together
- [Kering Ventures](https://shizune.co/investors/profile/kering-ventures) — VC Fund, 1 deal together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 1 deal together

## About Kering

VC Fund · Paris, France

Kering (formerly PPR) is a holding company whose portfolio includes two fashion segments: luxury (Gucci, Bottega Veneta, Saint Laurent, Alexander McQueen, Balenciaga, Brioni, Christopher Kane, McQ, Stella McCartney, Tomas Maier, Sergio Rossi, Boucheron, Dodo, Girard-Perregaux, JEANRICHARD, Pomellato and Qeelin) and sport & lifestyle (Puma,Volcom, Cobra, Electric and Tretorn).

5 contacts available at Kering.

| Name | Title | Profile |
| --- | --- | --- |
| Armelle Poulou | Directeur Financement, Trésorerie et Assurance | https://shizune.co/investors/profile/armelle-poulou |
| Jean-Marc Duplaix | CFO | https://shizune.co/investors/profile/jean-marc-duplaix |
| Laurent Claquin | Head of Kering Americas | https://shizune.co/investors/profile/laurent-claquin-0f27 |
| Louise Beveridge | Senior Vice-President Communications | https://shizune.co/investors/profile/louise-beveridge |
| Marie-Claire Daveu | Chief Sustainability Officer and Head of International Institutional Affairs | https://shizune.co/investors/profile/marie-claire-daveu |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Marie-Claire Daveu invest in?

Marie-Claire Daveu invests primarily in Biotechnology, Fashion and 3D Printing startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Marie-Claire Daveu last invest?

The most recent investment recorded for Marie-Claire Daveu closed in Jan 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co